Novo Nordisk lowered its 2025 outlook as Ozempic and Wegovy sales lag, triggering a 20% premarket stock crash and billions in market value loss.
Novo Nordisk Stock Drops 20% After Cutting 2025 Sales Forecast
Novo Nordisk lowered its 2025 outlook as Ozempic and Wegovy sales lag, triggering a 20% premarket stock crash and billions in market value loss.